Implantable Cardioverter/Defibrillators in the Primary Prevention of Sudden Death: We Know What to Do but Are We Doing It?
- 2 January 1960
- journal article
- comment
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 172 (1), 67-68
- https://doi.org/10.1001/archinternmed.2011.468
Abstract
Opinion from JAMA — Implantable Cardioverter/Defibrillators in the Primary Prevention of Sudden Death — We Know What to Do but Are We Doing It? — Comment on — “Optimal Medical Therapy Use Among Patients Receiving Implantable Cardioverter-Defibrillators”Keywords
This publication has 5 references indexed in Scilit:
- Effect of Renal Function on Survival After Implantable Cardioverter Defibrillator PlacementThe American Journal of Cardiology, 2010
- Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice GuidelineJournal of Cardiac Failure, 2010
- Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failureAmerican Heart Journal, 2008
- Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular DysfunctionJournal of the American College of Cardiology, 2008
- Prospective Evaluation of Beta-Blocker Use at the Time of Hospital Discharge as a Heart Failure Performance Measure: Results From OPTIMIZE-HFJournal of Cardiac Failure, 2007